STOCK TITAN

Versigent CFO granted 480.603 dividend rights

Versigent’s CFO received a dividend-linked grant of 480.603 derivative rights tied to existing restricted stock units, increasing his direct derivative holdings.

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Versigent PLC (symbol: VGNT) is the issuer of record for a Form 4 filing submitted to the SEC. Ostermann Douglas R reported acquisition or exercise transactions in this Form 4 filing.

Versigent PLC (VGNT) reported that Chief Financial Officer Ostermann Douglas R received a grant of 480.603 dividend equivalent rights on September 18, 2026. These derivative rights relate to existing restricted stock unit grants and are the economic equivalent of the same number of Versigent ordinary shares.

The dividend equivalent rights accrued because Versigent declared and paid a dividend, and they will vest on the same schedule as the underlying restricted stock units. No Rule 10b5-1 trading plan is indicated for this award, and the CFO’s direct holdings of these rights increased to 480.603 following the transaction.

Positive

  • None.

Negative

  • None.
Insider Ostermann Douglas R
Role Chief Financial Officer
Type Security Shares Price Value
Grant/Award Dividend Equivalent Rights F1 480.603 $0.00 $0.00
Holdings After Transaction: Dividend Equivalent Rights — 480.603 contracts (Direct)
Footnotes (1)
  1. F1. The dividend equivalent rights accrued on grants of restricted stock units as a result of a dividend declared and paid by the issuer. These rights vest on the same schedule as the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of the issuer's ordinary shares.
Dividend equivalent rights granted 480.603 rights Grant to CFO Ostermann Douglas R on September 18, 2026
Underlying ordinary shares 480.603 shares Each dividend equivalent right equals one ordinary share
Price per dividend equivalent right $0.00 per right Reported transaction price for the September 18, 2026 grant
Holdings of dividend equivalent rights after transaction 480.603 rights Direct derivative position following the reported grant
Dividend Equivalent Rights financial
"The dividend equivalent rights accrued on grants of restricted stock units"
Dividend equivalent rights are promises that mirror the cash payments shareholders get from a company’s profits, but they are paid to holders of certain awards (like stock options or restricted stock units) rather than to actual shares. Think of them as a paycheck top‑up that matches dividends while the award is not yet a real stock, and they matter to investors because they add to employee compensation costs and potential share dilution, affecting company profitability and per‑share value.
restricted stock units financial
"The dividend equivalent rights accrued on grants of restricted stock units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
ordinary shares financial
"Each dividend equivalent right is the economic equivalent of one share of the issuer's ordinary shares"
Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Versigent (VGNT) disclose in this Form 4 for its CFO?

Versigent reported that its Chief Financial Officer, Ostermann Douglas R, received a grant of 480.603 dividend equivalent rights on September 18, 2026, tied to existing restricted stock unit awards and economically equivalent to the same number of ordinary shares.

How many dividend equivalent rights were granted to the VGNT CFO?

The CFO was granted 480.603 dividend equivalent rights. Each right is the economic equivalent of one ordinary share of Versigent PLC, and these rights increased his direct derivative holdings to the same amount after the transaction.

What are the dividend equivalent rights reported by Versigent (VGNT)?

The dividend equivalent rights are derivative awards that accrued on restricted stock units because Versigent declared and paid a dividend. Each right is the economic equivalent of one ordinary share and vests on the same schedule as the related restricted stock units.

At what price were the dividend equivalent rights granted to the VGNT CFO?

The dividend equivalent rights were reported with a transaction price of $0.00 per right. They accrued as a result of a dividend declared and paid by Versigent and are tied to existing restricted stock unit grants rather than being purchased in the market.

Do the VGNT CFO’s dividend equivalent rights vest immediately?

No. Versigent states that the dividend equivalent rights vest on the same schedule as the restricted stock units to which they relate, meaning their vesting follows the original RSU grant terms rather than vesting immediately.

Was the VGNT CFO’s Form 4 transaction under a Rule 10b5-1 plan?

No. The filing’s Rule 10b5-1 checkbox is not affirmed, and there is no footnote indicating a trading plan. The grant is reported as a compensation-related acquisition of derivative rights, not as a trade under a pre-arranged plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Ostermann Douglas R

(Last)(First)(Middle)
SPITALSTRASSE 5,

(Street)
SCHAFFHAUSEN8200

(City)(State)(Zip)

SWITZERLAND

(Country)
2. Issuer Name and Ticker or Trading Symbol
Versigent PLC [ VGNT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Financial Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/18/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Dividend Equivalent Rights(1)09/18/2026A480.603 (1) (1)Ordinary Shares480.603$0.00480.603D
Explanation of Responses:
1. The dividend equivalent rights accrued on grants of restricted stock units as a result of a dividend declared and paid by the issuer. These rights vest on the same schedule as the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of the issuer's ordinary shares.
/s/ Janis N. Acosta, Attorney-in-fact for Douglas R. Ostermann09/22/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading